97-13430. Agency Forms Undergoing Paperwork Reduction Act Review  

  • [Federal Register Volume 62, Number 99 (Thursday, May 22, 1997)]
    [Notices]
    [Pages 28026-28027]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-13430]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [30DAY-10-97]
    
    
    Agency Forms Undergoing Paperwork Reduction Act Review
    
        The Centers for Disease Control and Prevention (CDC) publishes a 
    list of information collection requests under review by the Office of 
    Management and Budget (OMB) in compliance with the Paperwork Reduction 
    Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
    the CDC Reports Clearance Office on (404) 639-7090. Send written 
    comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
    Executive Office Building, Room 10235; Washington, DC 20503. Written 
    comments should be received within 30 days of this notice.
    
    Proposed Project
    
        1. AIDS Prevention and Surveillance Project Reports, (0920-0208)--
    Extension--CDC funds cooperative agreements for 65 HIV Prevention 
    Projects (50 states, 6 cities, 7 territories, Washington, D.C., and 
    Puerto Rico). The cooperative agreements support counseling, testing, 
    referral, and partner notification programs conducted by official 
    public health agencies of states, territories, and localities (project 
    areas). HIV counseling and testing in STD clinics, Women's Health 
    Centers, Drug Treatment Centers, and other health agencies has been 
    described as a primary prevention strategy of the national HIV 
    Prevention Program. These project areas have increased HIV counseling 
    and testing activities to specifically reach more minorities and women 
    of child bearing age.
        CDC is responsible for monitoring and evaluating HIV prevention 
    activities conducted under the cooperative agreement. Counseling and 
    testing programs are a major component of the HIV Prevention Program. 
    Without data to measure the impact of counseling and testing programs, 
    priorities cannot be assessed and redirected to prevent further spread 
    of the virus in the general population. CDC needs information from all 
    project areas on the number of at-risk persons tested and the number 
    positive for HIV. The HIV Counseling and Testing Report Form provides a 
    simple yet complete means to collect this information. We are 
    requesting a three year extension for this study. The total annual 
    burden hours are 219.
    
    ----------------------------------------------------------------------------------------------------------------
                                                                                              Average               
                                                                    No. of       No. of       burden/       Total   
                            Respondents                          respondents   responses/  response (in   burden (in
                                                                               respondent      hrs.)        hrs.)   
    ----------------------------------------------------------------------------------------------------------------
    Manual Form Project Areas..................................           22            4          2             176
    Scan Form Project Areas....................................           43            4          0.25           43
    ----------------------------------------------------------------------------------------------------------------
    
        2. Employee Vital Status Letter (0920-0035)--Extension--The 
    employee vital status letter is an update of a letter originally 
    approved by OMB in 1977 and last approved in 1994. The vital status 
    letter is used for a type of study known as ``retrospective 
    mortality.'' The retrospective mortality study involves the 
    identification of a study population of present and former workers who 
    were exposed to a toxic substance in the workplace that is suspected of 
    causing a long term adverse health effect to the exposed workers. The 
    adverse health effects may be identified by observing the cause 
    specific mortality in the study population and comparing that to the 
    expected mortality. The study populations are identified through 
    employment records of past and present workers in given industries 
    where the suspected toxins are found. In order to identify these 
    deaths, it is necessary to determine the vital status (i.e., whether 
    the individual is alive or deceased) of all members of the study 
    population as of a given cut-off date and then obtain the medical 
    certification of cause of death on all deceased members.
        This letter is sent to study cohort members as a last resort. If 
    the vital status of an individual cannot be determined from a number of 
    available data sources (such as the National Death Index and the Social 
    Security Administration), the letter is sent to determine if the 
    respondent is deceased or alive--if deceased, the data and place of 
    death is requested from next of kin. The total annual burden hours are 
    42.
    
    ----------------------------------------------------------------------------------------------------------------
                                                                               No. of     Avg. burden/              
                           Respondents                           No. of      responses/   response (in  Total burden
                                                               respondents   respondent       hrs.)       (in hrs.) 
    ----------------------------------------------------------------------------------------------------------------
    Workers.................................................          252             1          .166            42 
    ----------------------------------------------------------------------------------------------------------------
    
    
    [[Page 28027]]
    
        Dated: May 16, 1997.
    Wilma G. Johnson,
    Acting Associate Director for Policy Planning And Evaluation, Centers 
    for Disease Control and Prevention (CDC).
    [FR Doc. 97-13430 Filed 5-21-97; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
05/22/1997
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
97-13430
Pages:
28026-28027 (2 pages)
Docket Numbers:
30DAY-10-97
PDF File:
97-13430.pdf